Cargando…
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
SIMPLE SUMMARY: Glioblastoma is the most common of primary brain tumors, accounting for approximately 50% of intracranial malignancies. It is an aggressive neoplasm with a poor prognosis. To date, the standard of care is a treatment involving maximal surgery, radiotherapy concurrent with and followe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296384/ https://www.ncbi.nlm.nih.gov/pubmed/37370860 http://dx.doi.org/10.3390/cancers15123251 |